Authors' responses in response to the letter from Ambrose
- PMID: 25452650
- DOI: 10.1542/peds.2014-2901C
Authors' responses in response to the letter from Ambrose
Comment on
-
Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection.Pediatrics. 2014 Aug;134(2):415-20. doi: 10.1542/peds.2014-1665. Pediatrics. 2014. PMID: 25070315
-
Severe RSV disease in preterm infants born at 29 to 35 weeks' gestation in the United States.Pediatrics. 2014 Dec;134(6):e1781. doi: 10.1542/peds.2014-2901A. Pediatrics. 2014. PMID: 25452648 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
